Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 132


Evaluation of the PIMA point-of-care CD4 analyzer in VCT clinics in Zimbabwe.

Mtapuri-Zinyowera S, Chideme M, Mangwanya D, Mugurungi O, Gudukeya S, Hatzold K, Mangwiro A, Bhattacharya G, Lehe J, Peter T.

J Acquir Immune Defic Syndr. 2010 Sep;55(1):1-7. doi: 10.1097/QAI.0b013e3181e93071.


The reliability of point-of-care CD4 testing in identifying HIV-infected pregnant women eligible for antiretroviral therapy.

Mnyani CN, McIntyre JA, Myer L.

J Acquir Immune Defic Syndr. 2012 Jul 1;60(3):260-4. doi: 10.1097/QAI.0b013e318256b651.


Multisite evaluation of a point-of-care instrument for CD4(+) T-cell enumeration using venous and finger-prick blood: the PIMA CD4.

Diaw PA, Daneau G, Coly AA, Ndiaye BP, Wade D, Camara M, Mboup S, Kestens L, Dieye TN.

J Acquir Immune Defic Syndr. 2011 Dec 1;58(4):e103-11. doi: 10.1097/QAI.0b013e318235b378.


Comparison of point-of-care versus laboratory-based CD4 cell enumeration in HIV-positive pregnant women.

Myer L, Daskilewicz K, McIntyre J, Bekker LG.

J Int AIDS Soc. 2013 Sep 16;16:18649. doi: 10.7448/IAS.16.1.18649.


[Evaluation of PIMA analyzer detecting CD4 cell count of venous and capillary blood in HIV-infected individuals].

Su YZ, Jia MH, Jiang Y, Xiao Y, Shi YH, Chen HC, Yan WY, Yang L, Yang CJ, Chen M, Dong LJ, Ma YL.

Zhonghua Yu Fang Yi Xue Za Zhi. 2013 Nov;47(11):1001-5. Chinese.


Performance evaluation of the Alere PIMA CD4 test for monitoring HIV-infected individuals in resource-constrained settings.

Sukapirom K, Onlamoon N, Thepthai C, Polsrila K, Tassaneetrithep B, Pattanapanyasat K.

J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):141-7. doi: 10.1097/QAI.0b013e31822866a2.


Evaluation of PIMA point-of-care CD4 analyzer in Yunnan, China.

Liang J, Duan S, Ma YL, Wang JB, Su YZ, Zhang H, Ou CY, Hao L, Qi MS, Bulterys M, Westerman L, Jiang Y, Xiao Y.

Chin Med J (Engl). 2015 Apr 5;128(7):890-5. doi: 10.4103/0366-6999.154283.


Evaluation of portable point-of-care CD4 counter with high sensitivity for detecting patients eligible for antiretroviral therapy.

Manabe YC, Wang Y, Elbireer A, Auerbach B, Castelnuovo B.

PLoS One. 2012;7(4):e34319. doi: 10.1371/journal.pone.0034319. Epub 2012 Apr 19.


Impact on ART initiation of point-of-care CD4 testing at HIV diagnosis among HIV-positive youth in Khayelitsha, South Africa.

Patten GE, Wilkinson L, Conradie K, Isaakidis P, Harries AD, Edginton ME, De Azevedo V, van Cutsem G.

J Int AIDS Soc. 2013 Jul 4;16:18518. doi: 10.7448/IAS.16.1.18518.


Rapid point-of-care CD4 testing at mobile HIV testing sites to increase linkage to care: an evaluation of a pilot program in South Africa.

Larson BA, Schnippel K, Ndibongo B, Xulu T, Brennan A, Long L, Fox MP, Rosen S.

J Acquir Immune Defic Syndr. 2012 Oct 1;61(2):e13-7.


Utility of the point of care CD4 analyzer, PIMA, to enumerate CD4 counts in the field settings in India.

Thakar M, Mahajan B, Shaikh N, Bagwan S, Sane S, Kabra S, Rewari B, Shaukat M, Singh N, Trevor P, Paranjape R.

AIDS Res Ther. 2012 Sep 21;9(1):26. doi: 10.1186/1742-6405-9-26.


Performance evaluation of the Pima™ point-of-care CD4 analyser using capillary blood sampling in field tests in South Africa.

Glencross DK, Coetzee LM, Faal M, Masango M, Stevens WS, Venter WF, Osih R.

J Int AIDS Soc. 2012 Jan 30;15(1):3. doi: 10.1186/1758-2652-15-3.


Evaluation of PIMA point-of-care CD4 testing in a large UK HIV service.

Herbert S, Edwards S, Carrick G, Copas A, Sandford C, Amphlett M, Benn P.

Sex Transm Infect. 2012 Oct;88(6):413-7. Epub 2012 Apr 27.


Performance of the PointCare NOW system for CD4 counting in HIV patients based on five independent evaluations.

Bergeron M, Daneau G, Ding T, Sitoe NE, Westerman LE, Stokx J, Jani IV, Coetzee LM, Scott L, De Weggheleire A, Boel L, Stevens WS, Glencross DK, Peter TF.

PLoS One. 2012;7(8):e41166. doi: 10.1371/journal.pone.0041166. Epub 2012 Aug 9. Erratum in: PLoS One. 2012;7(9). doi: 10.1371/annotation/71a6d947-c034-4749-a33d-971284ea3408.


WHO multicenter evaluation of FACSCount CD4 and Pima CD4 T-cell count systems: instrument performance and misclassification of HIV-infected patients.

Wade D, Daneau G, Aboud S, Vercauteren GH, Urassa WS, Kestens L.

J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):e98-107. doi: 10.1097/QAI.0000000000000214.


Operational challenges in delivering CD4 diagnostics in sub-Saharan Africa.

Thairu L, Katzenstein D, Israelski D.

AIDS Care. 2011 Jul;23(7):814-21. doi: 10.1080/09540121.2010.541416. Epub 2011 Jun 24.


Multisite evaluation of point of care CD4 testing in Papua New Guinea.

Malagun M, Nano G, Chevallier C, Opina R, Sawiya G, Kivavia J, Kalinoe A, Nathaniel K, Kaminiel O, Millan J, Carmone A, Dini M, Palou T, Topma K, Lavu E, Markby J.

PLoS One. 2014 Nov 26;9(11):e112173. doi: 10.1371/journal.pone.0112173. eCollection 2014.


Acceptability and challenges of implementing voluntary counselling and testing (VCT) in rural Zimbabwe: evidence from the Regai Dzive Shiri Project.

Chirawu P, Langhaug L, Mavhu W, Pascoe S, Dirawo J, Cowan F.

AIDS Care. 2010 Jan;22(1):81-8. doi: 10.1080/09540120903012577.


New BD FACSCount CD4 reagent system for simultaneous enumeration of percent and absolute CD4 T-lymphocytes in HIV-1-infected pediatric patients.

Pattanapanyasat K, Sukapirom K, Kowawisatsut L, Thepthai C.

Cytometry B Clin Cytom. 2008;74 Suppl 1:S98-106. doi: 10.1002/cyto.b.20415.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk